Company: YEXT
Filing Date: 2025-04-28
Form Type: ARS
Source: 0001614178-25-000048
Chunk: 135

Company: Yext, Inc.
Filing Date: 2025-04-28
Form: ARS
Chunk 135
---
 6.26 2.20 $ 989 Granted — $ — Exercised (366,671) $ 3.52 Forfeited or canceled (88,689) $ 8.45 Balance, January 31, 2025 1,566,134 $ 6.78 1.48 $ 450 Vested and expected to vest 1,566,134 $ 6.78 1.48 $ 450 Exercisable at January 31, 2025 1,566,134 $ 6.78 1.48 $ 450 The aggregate intrinsic value of options vested and expected to vest and exercisable is calculated based on the difference between the exercise price and the fair value of the Company’s common stock as of January 31, 2025. The fair value of the common stock is the Company’s closing stock price as reported on the New York Stock Exchange. The aggregate intrinsic value of exercised options was $0.8 million, $6.3 million and $0.9 million for the fiscal years ended January 31, 2025, 2024 and 2023, respectively, and is calculated based on the difference between the exercise price and the fair value of the Company’s common stock as of the exercise date. Restricted Stock and Restricted Stock Units The following table summarizes the activity related to the Company's restricted stock and restricted stock units ("RSUs"): Outstanding Weighted-Average Grant Date Fair Value Balance, January 31, 2024 9,790,748 $ 7.54 Granted 8,797,252 $ 5.85 Vested and converted to shares (5,437,573) $ 7.46 Forfeited or canceled (2,835,228) $ 6.71 Balance, January 31, 2025 10,315,199 $ 6.37 The estimated weighted-average grant date fair value of restricted stock and RSUs granted was $5.85, $8.28, and $5.71 per share for the fiscal years ended January 31, 2025, 2024, and 2023, respectively. The fair value of the common stock is the Company’s closing stock price as reported on the New York Stock Exchange. The total fair value of restricted stock and RSUs vested was $40.6 million, $40.7 million, and $63.5 million for the fiscal years ended January 31, 2025,